CompletedPhase 4

Effectiveness Trial to Evaluate Protection of Pregnant Women by Hepatitis E Vaccine in Bangladesh.

Bangladesh19,460 participantsStarted 2017-10-02

Plain-language summary

The aim of the study is to determine the effectiveness of hepatitis E virus vaccine given in women of child bearing age in preventing HEV disease during pregnancy among women in rural Bangladesh.

Who can participate

Age range16 Years – 39 Years

SexFEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Women aged 16-39 years * Living in Matlab area Exclusion Criteria: * Pregnancy * Allergic to vaccine components * Serious chronic diseases * Acute illness

What they're measuring

Effectiveness of HEV vaccine in preventing HEV diseases among women in Bangladesh

Timeframe: 2 years

Trial details

NCT IDNCT02759991

SponsorNorwegian Institute of Public Health

Sponsor typeOTHER_GOV

Study typeINTERVENTIONAL

Primary completion2019-09-30

View on ClinicalTrials.gov More Hepatitis E Infection trials